TOKYO, Japan, June 07, 2023 — CarbGeM Inc, a Japan-based startup focused on AI-based diagnostics, today announced four presentations addressing the problem of Antimicrobial Resistance (AMR) will be featured at the ASM Microbe taking place, June 15-19, 2023, in Houston.
Featured presentations include early clinical results from the company’s ongoing proof-of-concept study of the Point-of-Care Gram Staining System, PoCGS, as well as the AI-based smartphone app, BiTTE, which estimates the bacterial species in a Gram-stained sample.
In addition, preclinical results will be presented on a new thin-film transistor (TFT) image sensor that monitors bacterial growth on agar plates.
Details of the poster presentations are follows (all time in CDT):
Title: Automated point-of-care Gram staining system achieves the same quality of staining as an experienced microbiologist.
Date/Time: Friday June 16 from 10:30 am to 11:30 am and 4 pm to 5 pm
Session P043 – CPHM14 Practical Tools for Bench Technologists
Presenting Author: Hiroaki Ozaki
Title: A New Thin-Film Transistor Image Sensor for Early Detection of Bacterial Growth on Agar Plates
Date/Time: Friday June 16 from 10:30 am to 11:30 am and 4 pm to 5 pm
Session P032 – CPHM03 Diagnostic Bacteriology
Presenting Author: Makoto Taketani
Title: Distinguishing between susceptible and resistant Neisseria gonorrhoeae by image recognition AI
Date/Time: Saturday June 17 from 10:30 am to 11:30 am and 4 pm to 5 pm
Session P110 – CPHM03 Diagnostic Bacteriology
Presenting Author: Reiichi Ariizumi
Title: Research and Development of Image Recognition AI to Estimate Bacterial Species Using Gram Stain Findings in Urine Specimens
Date/Time: Saturday June 17 from 10:30 am to 11:30 am and 4 pm to 5 pm
Session P110 – CPHM03 Diagnostic Bacteriology
Presenting Author: Isao Miyatsuka
Through the fusion of biology and digital technology, CarbGeM aims to apply its proprietary AI analysis technology to the field of bacterial infectious diseases. CarbGeM will accelerate industry-academia collaboration with domestic and overseas academia, companies, etc., and contribute to solving the global issue of drug resistance through open innovation.
For more information, please visit the company website at https://carbgem.com/en/
